... an AAV5 mediated gene therapy, was less safe than BioMarin had led investors to believe; (2) BMN 307's safety profile made it likely that the ...
https://www.google.com/url?rct=j&sa=t&url=https://www.yahoo.com/now/rosen-leading-longstanding-firm-encourages-221500832.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNG_nAvuk4KIWcPfiM3S2N2ypQUYGA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.